Skip to main content

You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

EmTech Europe
EmTech Europe
    Times are shown in your local time zone GMT


    Explore the event Agenda

    Filter & Search
    Session Type
    Close Filters
    02 July 2021
    9:00 am - 9:30 am - 02 July 2021

    Opening Day 2

    Plenary Room

    9:00 am

    Paul Frew, MLA, Minister for the Economy

    9:05 am

    Marga Hoek, Author, The Trillion Dollar Shift
    02 July 2021
    9:30 am - 12:20 pm - 02 July 2021


    Plenary Room
    The Covid-19 Pandemic continues to put healthcare services under unprecedented pressure. Yet there
    are technological breakthroughs to navigate this crisis and usher in a healthier future across many
    other fields of medicine. How is the innovative use of data across Europe being used to improve health
    outcomes? Practitioners and thought leaders examine emerging solutions in connected health and
    telemedicine, and breakthroughs in the development of Messenger RNA vaccines for Covid. How can
    these advances be applied to tackle other healthcare delivery issues and disease states?

    9:30 am

    Brian O’Connor, Chair European Connected Health Alliance

    9:40 am

    Artificial Intelligence, blockchain, chatbots and personalised mobile apps are among the advances in
    technology being utilised to transform healthcare. Meet the experts on the frontlines of the healthcare
    revolution and hear about the innovative work making a real difference in the lives of patients.
    Moderator: Bleddyn Rees, Chair of the Digital Health Society (DHS),
    Vice Chair of ECHAlliance
    Rachel Dunscombe, CEO at NHS Digital Academy, UK
    Tomaz Gornik, Co-Chair of the OpenEHR foundation, CEO, Better, Slovenia
    Liz Ashall-Payne CEO, ORCHA, UK

    10:25 am

    Sweden (population 10m) regularly ranks Number One in the European Innovation League Table and its status as
    a biotech hotspot – with its very own Medicon Valley — has been burnished by Swedish involvement in the
    development of the Moderna and AstraZeneca Covid vaccines. Does the country and its capital, Stockholm, long a
    magnet for Nobel Prize-winning scientists, offer a template for life sciences enterprise which can be copied by
    other regions? And what are the societal and governmental building blocks which underpin the city’s deserved
    reputation as an entrepreneurial powerhouse? We chat with acclaimed scientist and Moderna co-founder Kenneth
    R. Chien — who hails from the global life sciences capital of Boston but is a professor at the Karolinska Institute in
    Stockholm — to get his take.

    Moderator: Máirtín Ó Muilleoir, Host, EmTech Europe
    Kenneth R. Chien, Professor of Cardiovascular Research, Karolinska Institute, Sweden.

    10:50 am

    Personalised (or Precision) medicine has been in the last years a very disruptive concept pushed by the scientific  community and a few innovative businesses. In Europe, it is defined as the “a medical model using characterisation of individuals’ phenotypes and genotypes (e.g. molecular profiling, medical imaging, lifestyle data) for tailoring the right therapeutic strategy for the right person at the right time, and/or to determine the predisposition to  disease and/or to deliver timely and targeted prevention”. How such approaches could support the development  of better therapies and effective predictive, preventive or lifestyle measures? Could it avoid the exposure of   patients to unnecessary risks? Could it help to save some unnecessary costs for the healthcare systems? At which  stage of deployment are we nowadays? These are some of the questions our panel of high-level visionary experts  will answer presenting bold ideas such as the Personal Genome project and the human Digital twins. 

    Moderator: Angela Brand, Full Professor in the Department of International Health
    at Maastricht University, Netherlands
    Dr. Philippe Menu, Chief Medical O cer, Sophia Genetics, Switzerland
    Hans Lehrach, Director at Max Planck Institute for Molecular Genomics, Germany
    George Church, Winthrop Professor of Genetics at Harvard Medical School, USA

    11:30 am

    Over three decades, Gareth Graham has been investing in a brighter Belfast. His most recent headline development was the 240,000 sq ft Merchant Square in Belfast which has been leased to PwC, making it the  firm’s biggest office outside of London in the UK. However, Gareth, whose latest venture is Belfast
    Commerical Finance, believes the city is on the cusp of further exponential growth as international companies flock to a transformed region, attracted by its talent, quality universities, liveability and its unique post-Brexit  status affording it unfettered trade with both Britain and the EU. 
    Sponsored Talk

    11:35 am

    The creation of the European Health Data Space is a priority for the EU but what are the key technologies  which will ensure its success and how will it make a real difference to the health of Europe’s citizens? 
    Who are the researchers in academia and industry who will best leverage this data pool to enable scientific   breakthroughs in the treatment of illness and how will the regulatory environment hinder or help their work?

    Moderator: Julien Venne, Board Director ECHAlliance, Data Governance and Digital Health Researcher at United Nations University
    Jeroen Tas, CIO & CSO, Philips, Netherlands
    Markus Kalliola, Project Director EHDS at SITRA, Finland
    Loubna Bouarfa, HLEG on AI and CEO at OKRA
    Louisa Stüwe, International Policy Manager, Health Data Hub, France

    12:15 pm

    The Covid Vaccine supply chain: challenges and innovations.

    Kevin Nepveux, VP, P zer Global Supply, USA

    02 July 2021
    12:30 pm - 5:40 pm - 02 July 2021


    Plenary Room
    AI continues to develop rapidly. Whether it’s progress in tooling, increased availability of quality data, the
    development of skills and techniques, or simply the fact that machine learning algorithms have evolved; AI
    is increasingly affecting every person and human activity. How are AI related technologies being applied to
    society’s grand challenges and in what ways can AI research be directed to have an instrumental role in
    building a better, more sustainable and equitable future for all?

    12:30 pm

    Tom Gray, CTO, Kainos and Conference Curator, EmTech Europe

    12:35 pm

    Azeem Azhar, Creator, Exponential View, UK

    1:00 pm

    This session looks at both the positive incentive function of regulation alongside the negative compliance
    burden, and how these may play out in the context of the application and abuse of AI.

    Joanna Bryson, Hertie School, Berlin, Germany

    1:25 pm

    We are entering a new era of sophisticated, machine-speed attacks, where algorithms are battling  algorithms. Cyber-criminals are turning to AI to scale up their attacks and evade detection — and over  97% of industry professionals are concerned. Join Nicole Eagan in discussion with Máire Ó Neill, as they  discuss why organizations are turning to self-learning, autonomous technologies to help organizations in  the fight against modern cyber-attackers.

    Moderator: Tate Ryan-Mosely, Reporter, Data and Audio, MIT Technology Review
    Professor Máire O’Neill, Regius Professor in Electronics and Computer Engineering,
    ECIT, Queen’s University, Belfast
    Nicole Eagan, CSO & AI O cer, Darktrace in conversation with Tate Ryan-Mosley Reporter, Data and Audio, MIT Technology Review

    2:05 pm

    Increasingly, interacting with AI happens with no awareness., - be it Netflix tuning suggestions for bringing
    pleasure, or urban surveillance keeping populations safe (theoretically). In addition, technology is starting
    to disappear - either literally as sensors shrink to microscopic size, or cognitively as devices like Alexa
    speakers, Nest thermostats, Hue bulbs, etc become the background of a home. This is leading to an age of
    Ambient Computing. In this session, we look at the drivers and impacts of Invisible AI.

    Moderator: Will Heaven, Senior Editor for AI, MIT Technology Review 
    Barbara Fusinska, Engineering Manager, Twitter UK
    Leslie Nooteboom, Co-founder, Humanising Autonomy, London, UK

    2:40 pm

    Climate change has been identified as a key risk factor for the European banking sector in 2021. The latest  edition of the European Central Bank’s Financial Stability Review suggests that around 80% of European  banks are already exposed to climate-related physical risks. How can financial services institutions harness data to meet this challenge?

    Rachael Bland, Head of Data Analytics, Kainos
    Sponsored Talk

    2:50 pm

    In this session, examine the cutting edge of AI Research from University and Corporate Labs across Europe
    and meet the researchers who are shaping the future of AI.

    Opening Address: Nora Khaldi, Founder & CSO, Nuritas, Dublin
    Spotlight: Paul Duan, Founder Bayes Impact, France
    Spotlight: Andreas Cleve, CEO Corti, Denmark
    Spotlight: Bo Li, Assistant Professor, University of Illinois at Urbana-Champaign, USA
    Spotlight: Daniele Pucci, Researcher, Dynamic Interaction Control,
     Istituto Italiano di Tecnologia

    4:40 pm

    Nell Watson, Researcher in AI Ethics

    4:55 pm

    Public faith in democracy has been wounded in recent years. This is increasingly a factor within the ongoing
    political polarization across many societies, along with growing inequality. Yet, new technologies are
    enabling access to the domains of law, politics, finance, and decision-making in powerfully democratic and
    participatory ways.

    Moderator: William Crawley, Presenter, BBC NI
    Isabella Convertini, International Markets Director, What 3 Words, UK 
    Louis Rosenberg, CEO, Unanimous AI, California, USA
    Nell Watson, Researcher in AI Ethics

    02 July 2021
    5:25 pm - 5:25 pm - 02 July 2021

    Day 2 Close

    We use cookies to ensure you get the best experience on our platform and by continuing to use this site you agree that we can save them on your device. For more information, please read our privacy policy Privacy Policy